Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report
BioSpace
Fri, 07/14/23 - 11:56 am
Roche
Roivant
ulcerative colitis
Crohn's Disease
M&A
Korro Bio merges with off-pitch Frequency, hits Wall Street with $117M
Fierce Biotech
Fri, 07/14/23 - 11:54 am
M&A
reverse merger
Korro Bio
Frequency Therapeutics
Hungry for more, Lilly tops off weight loss pipeline with $1.9B deal to acquire Versanis
Fierce Biotech
Fri, 07/14/23 - 10:10 am
Eli Lilly
M&A
obesity
Versanis
bimagrumab
Illumina hit by EU with maximum fine for Grail acquisition
BioPharma Dive
Wed, 07/12/23 - 11:10 pm
Illumina
Grail
M&A
Europe
Biopharma’s green shoots thriving in summer sun as deal activity returns
Fierce Biotech
Tue, 07/11/23 - 11:18 pm
M&A
Eli Lilly
Siglion Therapeutics
DiCE Therapeutics
GSK
Bellus Health
Thermo Fisher Jumps into M&A Shortly After Layoffs
Medical Devices and Diagnostics Industry
Thu, 07/6/23 - 11:21 am
Thermo Fisher Scientific
M&A
Medtech
CorEvitas
Teva weighs sale of $2B API business as CEO Richard Francis embarks on 'Pivot to Growth' strategy: reports
Fierce Pharma
Thu, 07/6/23 - 10:13 am
Teva Pharmaceutical
API
M&A
Medtech dealmaking grinds almost to a halt
EP Vantage
Thu, 07/6/23 - 10:12 am
Medtech
M&A
Abbott Labs
Augmedics
DistalMotion
HeartFlow
Noah Medical
Olympus
Saluda Medical
SD Biosensor
Thermo Fisher Scientific
Werfen Group
A New Day Is Coming for the Diagnostics Industry
Medical Devices and Diagnostics Industry
Wed, 07/5/23 - 07:09 pm
M&A
Medtech
diagnostics
EDP Biotech
New Day Diagnostics
FTC Scrutiny Chills Medtech M&A Market
Medical Devices and Diagnostics Industry
Wed, 07/5/23 - 11:47 am
Medtech
M&A
FTC
antitrust
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Immunome, Morphimmune reverse merge, with ex-Seagen CEO Clay Siegall to lead a year after domestic abuse arrest
Fierce Biotech
Fri, 06/30/23 - 11:42 am
Immunome
Morphimmune
Clay Siegall
M&A
reverse merger
Lilly to Buy European ADC Player Emergence Therapeutics
BioSpace
Fri, 06/30/23 - 10:20 am
Eli Lilly
M&A
Emergence Therapeutics
antibody-drug conjugate
oncology
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Healio
Fri, 06/30/23 - 10:10 am
Bausch + Lomb
M&A
Novartis
Xiidra
dry eye disease
Aurinia Pharmaceuticals stock surges 4% on plans to pursue a possible sale
Investing.com
Thu, 06/29/23 - 11:02 pm
Aurinia
M&A
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
Yahoo/Reuters
Thu, 06/29/23 - 11:56 am
Eli Lilly
M&A
Sigilon
cell therapy
diabetes
FTC proposes updates to merger review that could slow healthcare dealmaking
BioPharma Dive
Wed, 06/28/23 - 10:38 pm
FTC
M&A
antitrust
Restor3d inks Conformis buyout, adding hip and knee implants to portfolio
Medtech Dive
Wed, 06/28/23 - 10:51 am
Restor#d
M&A
ConforMIS
knee replacements
hip replacements
Medtech
devices
What Will AbbVie Buy Next?
Motley Fool
Wed, 06/28/23 - 10:01 am
AbbVie
M&A
Blueprint Medicines
Krystal Biotech
Shionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial Pipeline
BioSpace
Mon, 06/26/23 - 08:48 pm
Shionogi
M&A
Qpex Biopharma
antimicrobials
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »